Localization of CHMP2B-immunoreactivity in the brainstem of Lewy body disease

Neuropathology

Volumn 33, Issue 3, 2013, Pages 237-245

  Kurashige, Takashi ^a   Takahashi, Tetsuya ^a   Yamazaki, Yuu ^a   Hiji, Masanori ^a,b   Izumi, Yuishin ^b   Yamawaki, Takemori ^a   Matsumoto, Masayasu ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Mifukai Viha ra Hananosato Hospital   (Japan)

Author keywords

Alpha synuclein; CHMP2B (charged multivesicular body protein 2B); ESCRT (endosomal sorting complexes required for transport); Glial cytoplasmic inclusion; Lewy body

Indexed keywords

ALPHA SYNUCLEIN; ESCRT PROTEIN; MULTIVESICULAR BODY PROTEIN 2B; PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPHAGY; BRAIN STEM; CELL INCLUSION; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DISEASE CONTROL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFERIOR OLIVE; MALE; MOTONEURON NUCLEUS; NERVE CELL; PARKINSON DISEASE; PONTINE NUCLEUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SHY DRAGER SYNDROME; STAGING; VAGUS NERVE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AUTOPSY; BRAIN STEM; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; LEWY BODIES; LEWY BODY DISEASE; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE;

EID: 84878664294     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01346.x     Document Type: Article

References (52)

1. Goldman JE, Yen SH, Chiu FC etal. Lewy bodies of Parkinson's disease contain neurofilament antigens. Science 1983; 221: 1082-1084.
2. Jellinger K. Formation and development of Lewy pathology: a critical update. J Neurol 2009; 256 (Suppl 3): S270-S279.
3. Kuzuhara S, Mori H, Izumiyama N etal. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol 1988; 75: 345-353.
4. Schlossmacher MG, Frosch MP, Gai WP etal. Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies. Am J Pathol 2002; 160: 1655-1667.
5. Spillantini MG, Schmidt ML, Lee VM etal. α-Synuclein in Lewy bodies. Nature 1997; 388: 839-840.
6. Kato S, Nakamura H. Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies. Acta Neuropathol 1990; 79: 584-594.
7. Nakazato Y, Yamazaki H, Hirato J etal. Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 1990; 49: 521-530.
8. Papp MI, Kahn JE, Lantos PL. Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci 1989; 94: 79-100.
9. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994; 117: 235-243.
10. Fujiwara H, Hasegawa M, Dohmae N etal. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002; 4: 160-164.
11. Jellinger K. Recent advances in our understanding of neurodegeneration. J Neural Transm 2009; 116: 1111-1162.
12. Pan T, Kondo S, Le W etal. The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain 2008; 131: 1969-1978.
13. Komatsu M, Kominami E, Tanaka K. Autophagy and Neurodegeneration. Autophagy 2006; 2: 315-317.
14. Lee JA, Gao FB. ESCRT, autophagy, and frontotemporal dementia. BMB Reports 2008; 41: 827-832.
15. Chu CT. Autophagic stress in neuronal injury and disease. J Neuropathol Exp Neurol 2006; 65: 423-432.
16. Edinger AL, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004; 16: 663-669.
17. Bahr BA, Bendiske J. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 2002; 83: 481-489.
18. Nixon RA, Wegiel J, Kumar A etal. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 2005; 64: 113-122.
19. Anglade P, Vyas S, Javoy-Agid F etal. Apoptosis and autophagy in nigral neurons with Parkinson's disease. Histol Histopathol 1997; 12: 25-31.
20. Okamoto K, Hirai S, Iizuka T etal. Reexamination of granulovacuolar degeneration. Acta Neuropathol 1991; 82: 340-345.
21. Heiseke A, Aguib Y, Schatrzl HM. Autophagy, prion infection and their mutual interactions. Curr Issues Mol Biol 2010; 12: 87-98.
22. Hurley J, Boura E, Carlson LA etal. Membrane budding. Cell 2010; 143: 875-887.
23. Hurley JH, Hanson PI. Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol 2010; 11: 556-566.
24. Yamazaki Y, Matsubara T, Takahashi T etal. Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders. PLoS ONE 2011; 6: e26996.
25. Yamazaki Y, Takahashi T, Hiji M etal. Immunopositivity for ESCRT-III subunit CHMP2B in granulovacuolar degeneration of neurons in the Alzheimer's disease hippocampus. Neurosci Lett 2010; 477: 86-90.
26. Williams RL, Urbé S. The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol 2007; 8: 355-368.
27. Zabrocki P, Bastiaens I, Delay C etal. Phosphorylation, lipid raft interaction and traffic of α-synuclein in a yeast model for Parkinson. Biochim Biophys Acta 2008; 1783: 1767-1780.
28. Parkinson N, Ince PG, Smith MO etal. ALS phenotype with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 2006; 67: 1074-1077.
29. Skibinski G, Parkinson NJ, Brown JM etal. Mutations in the endosomal ESCRT III-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005; 37: 806-808.
30. Urwin H, Authier A, Nielsen JE etal. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum Mol Genet 2010; 19: 2228-2238.
31. Filimonenko M, Stuffers S, Raiborg C etal. Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease. J Cell Biol 2007; 179: 485-500.
32. Hasegawa T, Konno M, Baba T etal. The AAA-ATPase regulates extracellular secretin and lysosomal targeting of α-synuclein. PLoS ONE 2011; 6: e29460.
33. Gai WP, Yuan HX, Li XQ etal. In situ and in vitro study of colocalization and segregation of alpha synuclein, ubiquitin, and lipids in Lewy bodies. Exp Neurol 2002; 166: 324-333.
34. Kanazawa T, Uchihara T, Takahashi A etal. Three-layered structure shared between Lewy bodies and Lewy neuritis-three dimensional reconstruction of triple labeled sections. Brain Pathol 2008; 18: 415-422.
35. Utton MA, Noble WJ, Hill JE etal. Molecular motors implicated in the axonal transport of tau and α-synuclein. J Cell Sci 2005; 118: 4645-4654.
36. Higashi S, Moore DJ, Minegishi M etal. Localization of MAP1-LC3 in vulnerable neurons and Lewy bodies in brains of patients with dementia with Lewy bodies. J Neuropathol Exp Neurol 2011; 70: 264-280.
37. Tanji K, Mori F, Kakita A etal. Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease. Neurobiol Dis 2011; 43: 690-697.
38. Kuusisto E, Parkkinen L, Alafuzoff I. Morphogenesis of Lewy Bodies: dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62. J Neuropathol Exp Neurol 2003; 62: 1241-1253.
39. Fujita T, Doi M, Ogata T etal. Cerebral cortical pathology of sporadic olivopontocerebellar atrophy. J Neurol Sci 1993; 116: 41-46.
40. Ozawa T, Paviour D, Quinn N etal. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004; 127: 2657-2671.
41. Nishie M, Mori F, Fujisawa H etal. Accumulation of phosphorylated α-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy. Acta Neuropathol 2004; 107: 292-298.
42. Ishizawa K, Komori T, Arai N etal. Glial cytoplasmic inclusions and tissue injury in multiple system atrophy: a quantitative study in white matter (olivopontocerebellar system) and gray matter (nigrostriatal system). Neuropathology 2008; 28: 249-257.
43. Sakamoto M, Uchihara T, Nakamura A etal. Progressive accumulation of ubiquitin and disappearance of α-synuclein epitope in multiple system atrophy-associated glial cytoplasmic inclusions: triple fluorescence study combined with Gallyas-Braak method. Acta Neuropathol 2005; 110: 417-425.
44. Crews L, Spencer B, Desplats P etal. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of a-synucleinopathy. PLoS ONE 2010; 5: e9313.
45. Nixon RA, Cataldo AM. Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. J Alzheimers Dis 2006; 9: 277-289.
46. Gruenberg J, Griffiths G, Howell KE. Characterization of the early endosome and putative endocytotic carrier vesicles in vivo and with an assay of vesicle fusion in vitro. J Cell Biol 1989; 108: 1301-1316.
47. Gruenberg J, Stenmark H. The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 2004; 5: 317-323.
48. Duffy PE, Tennyson VM. Phase and electron microscopic observations of Lewy bodies and melanin granules in the substantia nigra and locus coeruleus in Parkinson's disease. J Neuropathol Exp Neurol 1965; 24: 398-414.
49. Jo E, McLaurin J, Yip CM etal. α-Synuclein membrane interactions and lipid specificity. J Biol Chem 2000; 44: 34328-34334.
50. Sharon R, Bar-Joseph I, Frosch MP etal. The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease. Neuron 2003; 37: 583-595.
51. Sharon R, Goldberg MS, Bar-Josef I etal. α-Synuclein occurs in lipid-rich high molecular weight complexes, bind fatty acids, and shows homology to the fatty acid-binding proteins. Proc Natl Acad Sci U S A 2001; 98: 9110-9115.
52. Emmanouilidou E, Melachroinou K, Roumeliotis T etal. Cell-produced α-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci 2010; 30: 6838-6851.